NEW YORK (GenomeWeb News) – The Singapore Ministry of Health has selected Qiagen to supply molecular diagnostic testing technologies to detect the H5N1 influenza virus, Qiagen said today.
Under the agreement, the Singapore Ministry of Health will buy Qiagen’s automated and manual sample-preparation technologies used to extract viral nucleic acids and its test kits designed to detect the H5N1 influenza strain.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.